Last update: Nov. 9, 2014
Not risky for breastfeeding or infant.
The high molecular weight of both standard or non-fractionated Heparin, and, so-called low molecular weight Heparin makes excretion into breast milk extremely difficult. Dalteparin has been shown not to be excreted into breast milk .
In addition, Heparins are inactivated in the GE tract where they are not absorbed which is reason to have a nil oral bioavailability.
Absence of anti-clotting activity in breastfed infants has been shown after treatment of the mother with Enoxaparin.
Risk of Heparin-induced Thrombocytopenia or Osteoporosis in the mother is lower with low weight Heparins.
Eleventh WHO Model List of Essential Drugs 2002: Compatible with breastfeeding.
We do not have alternatives for Heparin since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Confederación Nacional de Pediatría (CONAPEME) from Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM